Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Improved lymphoedema services would yield €5m in savings

By Mindo - 14th Mar 2018 | 35 views

A new national model of care for lymphoedema services is at its penultimate stage, awaiting sign-off at the HSE. It is hoped this process will be completed by the end of March.

It is understood the model of care recommends a ‘hub-and-spoke’ structure, with one specialist centre in each Community Healthcare Organisation and integration with acute, high-risk and palliative services.

The cost of providing a comprehensive service nationally is €3.25 million, according to an outline of the main recommendations from the working group charged with developing the new model of care.

The working group also estimated the cost of implementation to be €700,000 annually for the first two years.

However, ultimately, the savings achieved from implementing the recommendations would outweigh the costs.

While overall savings of €4.702 million annually are expected to be achieved in the first two years, they would rise to €5.402 million annually in subsequent years.

<strong><em>MI</em></strong> understands that an improvement in services would lead to a reduction in the need for patients accessing the HSE Treatment Abroad Scheme (TAS) and EU Cross-Border Healthcare Directive. There would also be a reduction in the need for contract services by private therapists, which cost three times more than HSE therapists, and less need for complex treatment due to prevention and early detection. 

The estimated cost in therapist’s time for complex treatment annually is €1,980, compared to €66 for mild lymphoedema. 

The new model would also lead to reduced incidence of cellulitis. It is estimated that 29 per cent of lymphoedema patients have cellulitis at least once a year. Of those patients, 22 per cent will be hospitalised and the average length of stay for cellulitis patients is 12 days due to complexity.

The document outlining the new model of care was due to be completed last year, but has been delayed. The forthcoming plan has been welcomed by Lymphoedema Ireland, which has strongly urged its implementation.

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read